Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 421 publications

Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.

Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 29, 2025

Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer.

Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer.

Journal: Medicine
Published: January 14, 2025

Convergent Total Synthesis of Ixabepilone and Its Analogues Enabled by Highly Efficient Asymmetric Hydrogenations.

Convergent Total Synthesis of Ixabepilone and Its Analogues Enabled by Highly Efficient Asymmetric Hydrogenations.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: December 17, 2024

Targeted and cytotoxic inhibitors used in the treatment of breast cancer.

Targeted and cytotoxic inhibitors used in the treatment of breast cancer.

Journal: Pharmacological research
Published: November 28, 2024

Single-cell transcriptomics analysis reveals dynamic changes and prognostic signature in tumor microenvironment of PDAC.

Single-cell transcriptomics analysis reveals dynamic changes and prognostic signature in tumor microenvironment of PDAC.

Journal: Scientific reports
Published: September 03, 2024

Clinical Manifestations of Neuropathic Pain and the Deleterious Effects of Chemotherapeutic Agents.

Clinical Manifestations of Neuropathic Pain and the Deleterious Effects of Chemotherapeutic Agents.

Journal: Current drug safety
Published: June 20, 2024

Total Synthesis of an Epothilone Analogue Based on the Amide-Triazole Bioisosterism.

Total Synthesis of an Epothilone Analogue Based on the Amide-Triazole Bioisosterism.

Journal: ChemPlusChem
Published: June 12, 2024

Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy.

Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy.

Journal: Advances in experimental medicine and biology
Published: May 28, 2024

Ixabepilone related angiographically silent macular edema.

Ixabepilone related angiographically silent macular edema.

Journal: European journal of ophthalmology
Published: May 03, 2024

Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analyses.

Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analyses.

Journal: BJC reports
Published: April 29, 2024

Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

Journal: British journal of cancer
Published: March 04, 2024

Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.

Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.

Journal: Frontiers in immunology
Published: September 10, 2023
Showing 1-12 of 421

Last Updated: 10/31/2025